(Q35255907)

7 August 2017

1 reference

title

Pharmacological profile of beta-adrenoceptor blockers with vasodilating properties, especially carvedilol--rationale for clinical use (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1350480

17 September 2022

author name string

G. Sponer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1350480

17 September 2022

W. Bartsch

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1350480

17 September 2022

K. Strein

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1350480

17 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1350480

17 September 2022

publication date

1 January 1992

1 reference

Journal of Molecular Medicine

7 August 2017

published in

1 reference

The Clinical Investigator

7 August 2017

volume

70 Suppl 1

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1350480

17 September 2022

volume

70 Suppl 1

1 reference

7 August 2017

page(s)

S20-6

1 reference

Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol

7 August 2017

cites work

1 reference

12 December 2020

Celiprolol: pharmacokinetics and duration of pharmacodynamic activity

1 reference

12 December 2020

Cardiovascular effects of bevantolol, a selective beta 1-adrenoceptor antagonist with a novel pharmacological profile

1 reference

12 December 2020

Long-term reduction of peripheral resistance with celiprolol and effects on left ventricular mass.

1 reference

12 December 2020

In vitro pharmacologic profile of the novel beta-adrenoceptor antagonist and vasodilator, carvedilol

1 reference

12 December 2020

The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.

1 reference

12 December 2020

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

12 December 2020

Effects of a new beta-blocker (CI 775) on left ventricular hemodynamics at rest and during exercise (author's transl)

1 reference

12 December 2020

Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol

1 reference

12 December 2020

Pharmacological characteristics of the stereoisomers of carvedilol

1 reference

12 December 2020

A pharmacokinetic evaluation of celiprolol in healthy elderly volunteers

1 reference

12 December 2020

Carvedilol (Kredex&reg;) Reduces Infarct Size in a Canine Model of Acute Myocardial Infarction

1 reference

12 December 2020

Bevantolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris

1 reference

12 December 2020

Hemodynamic differences between carvedilol and labetalol in the cutaneous circulation

1 reference

12 December 2020

Vasodilating properties of beta-adrenoceptor blockers with intrinsic sympathomimetic activity

1 reference

12 December 2020

Clinical experience with dual-acting drugs in hypertension

1 reference

12 December 2020

Haemodynamic characterization of a new beta-receptor blocker celiprolol (st1396) at rest and during ergometer exercise compared with propranolol (inderal) (author's transl)

1 reference

12 December 2020

Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study

1 reference

12 December 2020

Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia

1 reference

12 December 2020

Adrenergic vasoconstriction as a cause of inadequate hypotensive response to beta-adrenergic blockade

1 reference

12 December 2020

Vascular effects of carvedilol, a new beta-adrenoceptor antagonist with vasodilating properties, in isolated canine coronary artery

1 reference

12 December 2020

Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent

1 reference

12 December 2020

Alpha and beta adrenoceptor blocking action of carvedilol in the canine mesenteric artery and vein

1 reference

12 December 2020

Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.

1 reference

12 December 2020

[Comparative pharmacokinetics of the beta-1 receptor blookader celiprolol after a single oral administration in subjects with health kidneys and in patients with impaired renal function]

1 reference

12 December 2020

The pharmacology of carvedilol

1 reference

12 December 2020

Pharmacokinetics of the new antihypertensive agent nipradilol in rats. 1st communication: Metabolism and disposition after single oral administration of [14C]nipradilol.

1 reference

12 December 2020

Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00207607

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1350480

17 September 2022

1 reference